查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1585099

全球美容組合療法市場：產業分析、規模、佔有率、成長、趨勢、預測（2024-2031）

Combination Therapies In Aesthetics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 183 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

本報告研究分析了全球美容聯合療法市場，深入洞察市場結構，評估市場推動因素、趨勢、機會、推動因素和課題等關鍵市場動態。

目錄

第1章 內容提要

第二章市場介紹

第三章 全球美容聯合療法市場分析場景

  • 市場及預測
    • 市場規模及年成長

第四章市場動態

  • 宏觀經濟因素
  • 促進因素
    • 供給側
    • 需求方
  • 阻礙因素
  • 機會
  • 預測變量 - 相關性和影響
  • 聯合治療的最新進展

第五章全球美容組合療法市場分析與預測：依療法類型

  • 介紹
  • 基點佔有率 (BPS) 分析：依治療類型
  • 年成長預測：依治療類型
  • 市場價值預測：按治療類型
    • BTx-A/真皮填充劑
    • BTx-A/雷射
    • 雷射/外用藥物
    • 雷射/高頻
    • 真皮填充劑/外用藥物
    • 其他
  • 值得關注的趨勢
  • 市場吸引力：按治療類型

第六章全球美容組合療法市場分析與預測：依應用分類

  • 介紹
  • 基點佔有率（BPS）分析：依應用分類
  • 年成長預測：按應用分類
  • 市值預測：依用途
    • 脫髮
    • 紋身去除
    • 皮膚重修
    • 去除疤痕
    • 其他
  • 值得關注的趨勢
  • 市場吸引力：按應用分類

第七章全球美容組合療法市場分析與預測：依最終用途

  • 介紹
  • 基點佔有率（BPS）分析：依最終用途分類
  • 年成長預測：依最終用途分類
  • 市場價值預測：依最終用途分類
    • 醫院
    • 門診手術中心
    • 皮膚科診所
  • 值得關注的趨勢
  • 市場吸引力：依最終用途分類

第八章全球美容組合療法市場分析與預測：按地區

  • 基點佔有率（BPS）分析：按地區
  • 年成長預測：按地區
  • 市場價值預測：按地區
    • 北美
    • 拉丁美洲
    • 歐洲
    • 亞太地區
    • 中東/非洲
  • 市場吸引力：按地區

第九章北美美容組合療法市場分析與預測

  • 介紹
    • 基點佔有率（BPS）分析：依國家分類
    • 年成長預測：依國家分類
    • 主要規定
  • 市場價值預測：按治療類型
    • BTx-A/真皮填充劑
    • BTx-A/雷射
    • 雷射/外用藥物
    • 雷射/高頻
    • 真皮填充劑/外用藥物
    • 其他
  • 市值預測：依用途
    • 脫髮
    • 紋身去除
    • 皮膚重修
    • 去除疤痕
    • 其他
  • 市場價值預測：依最終用途分類
    • 醫院
    • 門診手術中心
    • 皮膚科診所
  • 市場價值預測：依國家分類
    • 美國
    • 加拿大
  • 市場吸引力分析
    • 按治療類型
    • 按用途
    • 按最終用途
    • 按國家
  • 值得關注的趨勢
  • 促進因素與抑制因素：影響分析

第10章拉丁美洲美容組合療法市場分析與預測

  • 介紹
    • 基點佔有率（BPS）分析：依國家分類
    • 年成長預測：依國家分類
    • 主要規定
  • 市場價值預測：按治療類型
    • BTx-A/真皮填充劑
    • BTx-A/雷射
    • 雷射/外用藥物
    • 雷射/高頻
    • 真皮填充劑/外用藥物
    • 其他
  • 市值預測：依用途
    • 脫髮
    • 紋身去除
    • 皮膚重修
    • 去除疤痕
    • 其他
  • 市場價值預測：依最終用途分類
    • 醫院
    • 門診手術中心
    • 皮膚科診所
  • 市場價值預測：依國家分類
    • 巴西
    • 墨西哥
    • 其他拉丁美洲
  • 市場吸引力分析
    • 按治療類型
    • 按用途
    • 按最終用途
    • 按國家
  • 值得關注的趨勢
  • 促進因素與抑制因素：影響分析

第十一章歐洲美容組合療法市場分析與預測

  • 介紹
    • 基點佔有率（BPS）分析：依國家分類
    • 年成長預測：依國家分類
    • 主要規定
  • 市場價值預測：按治療類型
    • BTx-A/真皮填充劑
    • BTx-A/雷射
    • 雷射/外用藥物
    • 雷射/高頻
    • 真皮填充劑/外用藥物
    • 其他
  • 市值預測：依用途
    • 脫髮
    • 紋身去除
    • 皮膚重修
    • 去除疤痕
    • 其他
  • 市場價值預測：依最終用途分類
    • 醫院
    • 門診手術中心
    • 皮膚科診所
  • 市場價值預測：依國家分類
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 歐洲其他地區
  • 市場吸引力分析
    • 按治療類型
    • 按用途
    • 按最終用途
    • 按國家
  • 值得關注的趨勢
  • 促進因素與抑制因素：影響分析

第十二章亞太地區美容組合療法市場分析與預測

  • 介紹
    • 基點佔有率（BPS）分析：依國家分類
    • 年成長預測：依國家分類
    • 主要規定
  • 市場價值預測：按治療類型
    • BTx-A/真皮填充劑
    • BTx-A/雷射
    • 雷射/外用藥物
    • 雷射/高頻
    • 真皮填充劑/外用藥物
    • 其他
  • 市值預測：依用途
    • 脫髮
    • 紋身去除
    • 皮膚重修
    • 去除疤痕
    • 其他
  • 市場價值預測：依最終用途分類
    • 醫院
    • 門診手術中心
    • 皮膚科診所
  • 市場價值預測：依國家分類
    • 日本
    • 中國
    • 印度
    • 澳大利亞/紐西蘭
    • ASEAN
    • 亞太其他地區
  • 市場吸引力分析
    • 按治療類型
    • 按用途
    • 按最終用途
    • 按國家
  • 值得關注的趨勢
  • 促進因素與抑制因素：影響分析

第十三章中東與非洲美容組合療法市場分析與預測

  • 介紹
    • 基點佔有率（BPS）分析：依國家分類
    • 年成長預測：依國家分類
    • 主要規定
  • 市場價值預測：按治療類型
    • BTx-A/真皮填充劑
    • BTx-A/雷射
    • 雷射/外用藥物
    • 雷射/高頻
    • 真皮填充劑/外用藥物
    • 其他
  • 市值預測：依用途
    • 脫髮
    • 紋身去除
    • 皮膚重修
    • 去除疤痕
    • 其他
  • 市場價值預測：依最終用途分類
    • 醫院
    • 門診手術中心
    • 皮膚科診所
  • 市場價值預測：依國家分類
    • 海灣合作委員會國家
    • 南非
    • 北非
    • 其他中東/非洲
  • 市場吸引力分析
    • 按治療類型
    • 按用途
    • 按最終用途
    • 按國家
  • 值得關注的趨勢
  • 促進因素與抑制因素：影響分析

第14章 競爭格局

  • 比賽儀表板
  • 市場佔有率分析：按公司分類（2024 年）
  • 公司簡介（詳細資訊 - 概述、財務、策略、最新趨勢）
    • Alma Lasers Ltd.
    • Lumenis Ltd.
    • Cynosure Inc.
    • Valeant Pharmaceutical International, Inc.
    • Galderma S.A.
    • Anika Therapeutics, Inc.
    • Speciality European Pharma
    • Merz Pharma GmbH & Co. KGaA
    • Cutera, Inc
    • Allergan
    • Syneron Medical Ltd

第15章 使用的假設和首字母縮略詞

第16章 研究方法論

簡介目錄
Product Code: PMRREP10987

Persistence Market Research has recently released a comprehensive report on the worldwide market for combination therapies in aesthetics. This report provides an in-depth analysis of critical market dynamics, including drivers, trends, opportunities, and challenges, offering a detailed overview of the market structure. This research publication presents exclusive data and insights projecting the growth trajectory of the global combination therapies in aesthetics market from 2024 to 2031.

Key Insights:

  • Combination Therapies in Aesthetics Market Size (2024E): US$3491 Mn
  • Projected Market Value (2031F): US$5,829.6 Mn
  • Global Market Growth Rate (CAGR 2024 to 2031): 7.6%

Combination Therapies in Aesthetics Market - Report Scope:

Combination therapies in aesthetics integrate various treatments, such as injectables, laser therapy, and topical treatments, to achieve optimal results for skin rejuvenation, contouring, and anti-aging. These therapies enhance treatment outcomes by leveraging the synergies of different modalities, addressing multiple aesthetic concerns in one regimen. This market caters to a wide range of aesthetic applications, including facial contouring, body shaping, and wrinkle reduction. Market growth is driven by the rising demand for minimally invasive aesthetic procedures, advancements in therapeutic combinations, and the increasing emphasis on personalized aesthetic care.

Market Growth Drivers:

The global market for combination therapies in aesthetics is driven by several factors, including the growing preference for non-surgical procedures that deliver effective results with minimal downtime. The desire for natural-looking aesthetic outcomes is encouraging the use of multiple, synergistic therapies. Additionally, advancements in laser technology, fillers, and skin care formulations are fueling the adoption of combination therapies. The increasing popularity of customized aesthetic solutions among a diverse client base, coupled with the influence of social media, is further propelling market growth.

Market Restraints:

Despite its growth potential, the combination therapies in aesthetics market faces challenges, such as high procedure costs and regulatory complexities. The need for skilled practitioners to administer these treatments effectively limits market expansion in some regions. Additionally, safety concerns and the potential side effects associated with combination therapies can impact patient acceptance and regulatory approval processes.

Market Opportunities:

The combination therapies in aesthetics market presents substantial growth opportunities driven by technological advancements and evolving consumer preferences. Innovations in multi-modality devices, customized formulations, and minimally invasive techniques are expanding treatment options. Furthermore, the growing demand for anti-aging solutions in the aging population provides an avenue for market players to introduce targeted therapies. Strategic collaborations between technology developers, aesthetic clinics, and healthcare providers can facilitate market penetration and support consumer education.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the combination therapies in aesthetics market globally?
  • Which treatment combinations are gaining traction across different aesthetic applications?
  • How are technological advancements influencing the adoption of combination therapies in aesthetics?
  • Who are the key players in the combination therapies in aesthetics market, and what strategies are they implementing to remain competitive?
  • What emerging trends and future prospects are shaping the global combination therapies in aesthetics market?

Competitive Intelligence and Business Strategy:

Leading players in the global combination therapies in aesthetics market, including Allergan, Galderma, and Merz Pharmaceuticals, are focusing on product innovation, clinical partnerships, and targeted marketing strategies to stay competitive. These companies invest heavily in R&D to develop new combination treatments and deliver safe, effective aesthetic outcomes. Collaborations with aesthetic clinics, dermatologists, and influencers are instrumental in broadening consumer reach and enhancing technology adoption. Additionally, an emphasis on personalized care and improved patient experience is helping these players cater to a diverse and growing aesthetic market.

Key Companies Profiled:

  • Alma Lasers Ltd.
  • Lumenis Ltd.
  • Cynosure Inc.
  • Valeant Pharmaceutical International, Inc.
  • Galderma S.A.
  • Anika Therapeutics, Inc.
  • Speciality European Pharma
  • Merz Pharma GmbH & Co. KGaA
  • Cutera, Inc
  • Allergan
  • Syneron Medical Ltd

Market Taxonomy

By Therapy Type

  • BTx-A/Dermal Filler
  • BTx-A/Laser
  • Laser/Topical Drug
  • Laser/Radiofrequency
  • Dermal Filler/Topical Drug

By Application Type

  • Hair Removal
  • Tattoo Removal
  • Skin Resurfacing
  • Scar Removal

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Dermatology Clinics

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Table of Contents

1. Executive Summary

2. Market Introduction

  • 2.1. Market Definition
  • 2.2. Market Taxonomy

3. Global Aesthetics Combination Therapy Market Analysis Scenario

  • 3.1. Market Size (US$ Mn) and Forecast
    • 3.1.1. Market Size and Y-o-Y Growth
    • 3.1.2. Absolute $ Opportunity

4. Market Dynamics

  • 4.1. Macro-economic Factors
  • 4.2. Drivers
    • 4.2.1. Supply Side
    • 4.2.2. Demand Side
  • 4.3. Restraints
  • 4.4. Opportunity
  • 4.5. Forecast Factors - Relevance and Impact
  • 4.6. Recent Advances in Combination Therapies

5. Global Aesthetics Combination Therapy MarketAnalysis and Forecasts, By Therapy Type

  • 5.1. Introduction
  • 5.2. Basis Point Share (BPS) Analysis By Therapy Type
  • 5.3. Y-o-Y Growth Projections By Therapy Type
  • 5.4. Market Value Forecast By Therapy Type, 2024-2031
    • 5.4.1. BTx-A/Dermal Filler
    • 5.4.2. BTx-A/Laser
    • 5.4.3. Laser/Topical Drug
    • 5.4.4. Laser/Radiofrequency
    • 5.4.5. Dermal Filler/Topical Drug
    • 5.4.6. Others
  • 5.5. Prominent Trends
  • 5.6. Market Attractiveness By Therapy Type

6. Global Aesthetics Combination Therapy Market Analysis and Forecasts, By Application

  • 6.1. Introduction
  • 6.2. Basis Point Share (BPS) Analysis By Application
  • 6.3. Y-o-Y Growth Projections By Application
  • 6.4. Market Value Forecast By Application, 2024-2031
    • 6.4.1. Hair Removal
    • 6.4.2. Tattoo Removal
    • 6.4.3. Skin Resurfacing
    • 6.4.4. Scar Removal
    • 6.4.5. Others
  • 6.5. Prominent Trends
  • 6.6. Market Attractiveness By Application

7. Global Aesthetics Combination Therapy Market Analysis and Forecasts, By End Use

  • 7.1. Introduction
  • 7.2. Basis Point Share (BPS) Analysis By End Use
  • 7.3. Y-o-Y Growth Projections By End Use
  • 7.4. Market Value Forecast By End Use, 2024-2031
    • 7.4.1. Hospitals
    • 7.4.2. Ambulatory Surgical Centers
    • 7.4.3. Dermatology Clinics
  • 7.5. Prominent Trends
  • 7.6. Market Attractiveness By End Use

8. Global Aesthetics Combination Therapy Market Analysis and Forecasts, By Region

  • 8.1. Basis Point Share (BPS) Analysis By Region
  • 8.2. Y-o-Y Growth Projections By Region
  • 8.3. Market Value Forecast By Region
    • 8.3.1. North America
    • 8.3.2. Latin America
    • 8.3.3. Europe
    • 8.3.4. APAC
    • 8.3.5. MEA
  • 8.4. Market Attractiveness By Region

9. North America Aesthetics Combination Therapy Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Basis Point Share (BPS) Analysis By Country
    • 9.1.2. Y-o-Y Growth Projections By Country
    • 9.1.3. Key Regulations
  • 9.2. Market Value Forecast By Therapy Type, 2024-2031
    • 9.2.1. BTx-A/Dermal Filler
    • 9.2.2. BTx-A/Laser
    • 9.2.3. Laser/Topical Drug
    • 9.2.4. Laser/Radiofrequency
    • 9.2.5. Dermal Filler/Topical Drug
    • 9.2.6. Others
  • 9.3. Market Value Forecast By Application, 2024-2031
    • 9.3.1. Hair Removal
    • 9.3.2. Tattoo Removal
    • 9.3.3. Skin Resurfacing
    • 9.3.4. Scar Removal
    • 9.3.5. Others
  • 9.4. Market Value Forecast By End Use, 2024-2031
    • 9.4.1. Hospitals
    • 9.4.2. Ambulatory Surgical Centers
    • 9.4.3. Dermatology Clinics
  • 9.5. Market Value Forecast By Country, 2024-2031
    • 9.5.1. US
    • 9.5.2. Canada
  • 9.6. Market Attractiveness Analysis
    • 9.6.1. By Therapy Type
    • 9.6.2. By Application
    • 9.6.3. By End Use
    • 9.6.4. By Country
  • 9.7. Prominent Trends
  • 9.8. Drivers and Restraints: Impact Analysis

10. Latin America Aesthetics Combination Therapy Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Basis Point Share (BPS) Analysis By Country
    • 10.1.2. Y-o-Y Growth Projections By Country
    • 10.1.3. Key Regulations
  • 10.2. Market Value Forecast By Therapy Type, 2024-2031
    • 10.2.1. BTx-A/Dermal Filler
    • 10.2.2. BTx-A/Laser
    • 10.2.3. Laser/Topical Drug
    • 10.2.4. Laser/Radiofrequency
    • 10.2.5. Dermal Filler/Topical Drug
    • 10.2.6. Others
  • 10.3. Market Value Forecast By Application, 2024-2031
    • 10.3.1. Hair Removal
    • 10.3.2. Tattoo Removal
    • 10.3.3. Skin Resurfacing
    • 10.3.4. Scar Removal
    • 10.3.5. Others
  • 10.4. Market Value Forecast By End Use, 2024-2031
    • 10.4.1. Hospitals
    • 10.4.2. Ambulatory Surgical Centers
    • 10.4.3. Dermatology Clinics
  • 10.5. Market Value Forecast By Country, 2024-2031
    • 10.5.1. Brazil
    • 10.5.2. Mexico
    • 10.5.3. Rest of Latin America
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Therapy Type
    • 10.6.2. By Application
    • 10.6.3. By End Use
    • 10.6.4. By Country
  • 10.7. Prominent Trends
  • 10.8. Drivers and Restraints: Impact Analysis

11. Europe Aesthetics Combination Therapy Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Basis Point Share (BPS) Analysis By Country
    • 11.1.2. Y-o-Y Growth Projections By Country
    • 11.1.3. Key Regulations
  • 11.2. Market Value Forecast By Therapy Type, 2024-2031
    • 11.2.1. BTx-A/Dermal Filler
    • 11.2.2. BTx-A/Laser
    • 11.2.3. Laser/Topical Drug
    • 11.2.4. Laser/Radiofrequency
    • 11.2.5. Dermal Filler/Topical Drug
    • 11.2.6. Others
  • 11.3. Market Value Forecast By Application, 2024-2031
    • 11.3.1. Hair Removal
    • 11.3.2. Tattoo Removal
    • 11.3.3. Skin Resurfacing
    • 11.3.4. Scar Removal
    • 11.3.5. Others
  • 11.4. Market Value Forecast By End Use, 2024-2031
    • 11.4.1. Hospitals
    • 11.4.2. Ambulatory Surgical Centers
    • 11.4.3. Dermatology Clinics
  • 11.5. Market Value Forecast By Country, 2024-2031
    • 11.5.1. UK
    • 11.5.2. France
    • 11.5.3. Germany
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Russia
    • 11.5.7. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Therapy Type
    • 11.6.2. By Application
    • 11.6.3. By End Use
    • 11.6.4. By Country
  • 11.7. Prominent Trends
  • 11.8. Drivers and Restraints: Impact Analysis

12. APAC Aesthetics Combination Therapy Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Basis Point Share (BPS) Analysis By Country
    • 12.1.2. Y-o-Y Growth Projections By Country
    • 12.1.3. Key Regulations
  • 12.2. Market Value Forecast By Therapy Type, 2024-2031
    • 12.2.1. BTx-A/Dermal Filler
    • 12.2.2. BTx-A/Laser
    • 12.2.3. Laser/Topical Drug
    • 12.2.4. Laser/Radiofrequency
    • 12.2.5. Dermal Filler/Topical Drug
    • 12.2.6. Others
  • 12.3. Market Value Forecast By Application, 2024-2031
    • 12.3.1. Hair Removal
    • 12.3.2. Tattoo Removal
    • 12.3.3. Skin Resurfacing
    • 12.3.4. Scar Removal
    • 12.3.5. Others
  • 12.4.Market Value Forecast By End Use, 2024-2031
    • 12.4.1. Hospitals
    • 12.4.2. Ambulatory Surgical Centers
    • 12.4.3. Dermatology Clinics
  • 12.5. Market Value Forecast By Country, 2024-2031
    • 12.5.1. Japan
    • 12.5.2. China
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. ASEAN
    • 12.5.6. Rest of APAC
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Therapy Type
    • 12.6.2. By Application
    • 12.6.3. By End Use
    • 12.6.4. By Country
  • 12.7. Prominent Trends
  • 12.8. Drivers and Restraints: Impact Analysis

13. MEA Aesthetics Combination Therapy Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Basis Point Share (BPS) Analysis By Country
    • 13.1.2. Y-o-Y Growth Projections By Country
    • 13.1.3. Key Regulations
  • 13.2. Market Value Forecast By Therapy Type, 2024-2031
    • 13.2.1. BTx-A/Dermal Filler
    • 13.2.2. BTx-A/Laser
    • 13.2.3. Laser/Topical Drug
    • 13.2.4. Laser/Radiofrequency
    • 13.2.5. Dermal Filler/Topical Drug
    • 13.2.6. Others
  • 13.3. Market Value Forecast By Application, 2024-2031
    • 13.3.1. Hair Removal
    • 13.3.2. Tattoo Removal
    • 13.3.3. Skin Resurfacing
    • 13.3.4. Scar Removal
    • 13.3.5. Others
  • 13.4. Market Value Forecast By End Use, 2024-2031
    • 13.4.1. Hospitals
    • 13.4.2. Ambulatory Surgical Centers
    • 13.4.3. Dermatology Clinics
  • 13.5. Market Value Forecast By Country, 2024-2031
    • 13.5.1. GCC Countries
    • 13.5.2. South Africa
    • 13.5.3. North Africa
    • 13.5.4. Rest of MEA
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Therapy Type
    • 13.6.2. By Application
    • 13.6.3. By End Use
    • 13.6.4. By Country
  • 13.7. Prominent Trends
  • 13.8. Drivers and Restraints: Impact Analysis

14. Competition Landscape

  • 14.1. Competition Dashboard
  • 14.2. Market Share Analysis By Company (2024)
  • 14.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 14.3.1. Alma Lasers Ltd.
    • 14.3.2. Lumenis Ltd.
    • 14.3.3. Cynosure Inc.
    • 14.3.4. Valeant Pharmaceutical International, Inc.
    • 14.3.5. Galderma S.A.
    • 14.3.6. Anika Therapeutics, Inc.
    • 14.3.7. Speciality European Pharma
    • 14.3.8. Merz Pharma GmbH & Co. KGaA
    • 14.3.9. Cutera, Inc
    • 14.3.10. Allergan
    • 14.3.11. Syneron Medical Ltd

15. Assumptions and Acronyms Used

16. Research Methodology